Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vimian Group

35.35 SEK-0.28 %18.9, 17.29
Less than 1K followers

VIMIAN

NASDAQ Stockholm

Health Care Providers

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
-0.28 %
+1.73 %
+15.52 %
+30.54 %
+16.51 %
+17.13 %
+41.72 %
-61.97 %
-54.87 %

Vimian Group is a group operating in animal health. The company, through its subsidiaries, delivers pharmaceuticals and technical solutions to veterinarians, laboratories and pet owners. The products include, for example, pharmaceuticals with associated clinical research and digital platforms for veterinary clinics. The company operates on a global level with headquarters in Stockholm.

Read more
Market cap
18.84B SEK
Turnover
10.41M SEK
Revenue
4.59B
EBIT %
15.72 %
P/E
54.54
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
22.10
2026

Interim report Q3'26

11.2
2027

Annual report '26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release17.09.2026, 10.00

Nomination Committee for Vimian’s 2027 Annual General Meeting

Vimian Group
Regulatory press release14.09.2026, 11.00

Change to the Vimian Group AB (publ) management team and appointment of new Head of M&A

Vimian Group
Regulatory press release31.08.2026, 17.30

Change in the number of shares and votes in Vimian

Vimian Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release27.08.2026, 07.30

Vimian Group AB (publ) appoints Hans Lord Skarplöth as Head of Specialty Pharma and member of the Vimian Group management team

Vimian Group
Regulatory press release31.07.2026, 17.30

Change in the number of shares and votes in Vimian

Vimian Group
Regulatory press release17.07.2026, 18.30

Vimian has resolved to issue and repurchase class D shares, class E1 2026 shares and class E2 2026 shares as part of its long-term incentive program 2026

Vimian Group
Vimian Group, Audiocast, Q2'26
Webcast17.07.2026, 09.00

Vimian Group, Audiocast, Q2'26

Vimian Group
Regulatory press release17.07.2026, 07.45

Vimian’s Interim Report for the second quarter of 2026

Vimian Group
Press release07.07.2026, 10.00

Invitation to Vimian’s Interim Report for the second quarter of 2026

Vimian Group
Regulatory press release30.06.2026, 17.30

Change in the number of shares and votes in Vimian

Vimian Group
Press release18.06.2026, 07.30

Subscription period for Vimian’s incentive program 2023-2026 has commenced

Vimian Group
Regulatory press release29.04.2026, 16.00

Press release from the Annual General Meeting in Vimian Group AB (publ) on 29 April 2026

Vimian Group
Vimian Group, Audiocast, Q1'26
Webcast29.04.2026, 09.00

Vimian Group, Audiocast, Q1'26

Vimian Group
Regulatory press release29.04.2026, 07.45

Vimian’s Interim Report for the first quarter of 2026

Vimian Group
Press release21.04.2026, 10.10

Invitation to Vimian’s Interim Report for the first quarter of 2026

Vimian Group
Regulatory press release19.03.2026, 07.45

Notice of Annual General Meeting in Vimian Group AB (publ)

Vimian Group
Regulatory press release19.03.2026, 07.30

Vimian publishes Annual Report and Sustainability Report for 2025

Vimian Group
Regulatory press release13.03.2026, 08.00

Vimian Group AB (publ) appoints Lotta Lundaas Head of Medtech and member of the Vimian Group management team

Vimian Group
Vimian Group, Audiocast, Q4'25
Webcast12.02.2026, 09.00

Vimian Group, Audiocast, Q4'25

Vimian Group
Regulatory press release12.02.2026, 07.45

Vimian’s year-end report for 2025

Vimian Group